Advisor Group Holdings, Inc. Seres Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 160 shares of MCRB stock, worth $1,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160

Previous 1,909 91.62%

Holding current value

$1,228

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$0.64 - $0.91 $1,119 - $1,591	-1,749 Reduced 91.62%	160 $0
Q4 2024 Jun 06, 2025	BUY	$0.55 - $0.98 $134 - $239	244 Added 152.5%	404 $0
Q3 2024 Nov 13, 2024	SELL	$0.7 - $1.48 $3,409 - $7,209	-4,871 Reduced 71.84%	1,909 $1,000
Q2 2024 Aug 13, 2024	BUY	$0.56 - $1.19 $3,512 - $7,464	6,273 Added 1237.28%	6,780 $4,000
Q1 2024 May 10, 2024	SELL	$0.75 - $1.56 $299,989 - $623,978	-399,986 Reduced 99.87%	507 $0
Q4 2023 Feb 12, 2024	BUY	$0.93 - $2.15 $191,729 - $443,246	206,161 Added 106.09%	400,493 $560,000
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $12,001 - $26,115	5,151 Added 2.72%	194,332 $462,000
Q2 2023 Aug 10, 2023	BUY	$4.67 - $6.55 $878,609 - $1.23 Million	188,139 Added 18055.57%	189,181 $906,000
Q1 2023 May 12, 2023	SELL	$4.95 - $6.09 $1,485 - $1,827	-300 Reduced 22.35%	1,042 $5,000
Q4 2022 Feb 10, 2023	SELL	$5.09 - $9.05 $16,496 - $29,331	-3,241 Reduced 70.72%	1,342 $7,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $12,393 - $25,495	3,541 Added 339.83%	4,583 $29,000
Q2 2022 Aug 10, 2022	BUY	$2.7 - $7.62 $135 - $381	50 Added 5.04%	1,042 $3,000
Q1 2022 May 04, 2022	BUY	$6.3 - $8.84 $18 - $26	3 Added 0.3%	992 $7,000
Q3 2021 Nov 05, 2021	SELL	$5.46 - $22.6 $3,210 - $13,288	-588 Reduced 37.29%	989 $7,000
Q2 2021 Aug 02, 2021	BUY	$18.46 - $24.36 $295 - $389	16 Added 1.02%	1,577 $38,000
Q1 2021 May 13, 2021	BUY	$17.66 - $28.92 $14,816 - $24,263	839 Added 116.2%	1,561 $32,000
Q4 2020 Feb 10, 2021	SELL	$23.25 - $37.73 $3,417 - $5,546	-147 Reduced 16.92%	722 $17,000
Q3 2020 Nov 12, 2020	SELL	$3.74 - $28.74 $36,393 - $279,668	-9,731 Reduced 91.8%	869 $24,000
Q1 2020 May 18, 2020	BUY	$2.64 - $3.82 $27,984 - $40,492	10,600 New	10,600 $38,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

39.5M

Call Options Held

103K

Put Options Held

53K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $953M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Seres Therapeutics, Inc. Transaction History